1. Home
  2. UPLD vs MRKR Comparison

UPLD vs MRKR Comparison

Compare UPLD & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Upland Software Inc.

UPLD

Upland Software Inc.

HOLD

Current Price

$0.56

Market Cap

19.6M

Sector

Technology

ML Signal

HOLD

Logo Marker Therapeutics Inc.

MRKR

Marker Therapeutics Inc.

HOLD

Current Price

$1.75

Market Cap

23.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UPLD
MRKR
Founded
2010
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.6M
23.0M
IPO Year
2014
2010

Fundamental Metrics

Financial Performance
Metric
UPLD
MRKR
Price
$0.56
$1.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$3.75
$10.00
AVG Volume (30 Days)
290.7K
153.5K
Earning Date
05-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
63.38
33.61
EPS
N/A
N/A
Revenue
$74,767,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.95
$644.02
P/E Ratio
N/A
N/A
Revenue Growth
6.95
N/A
52 Week Low
$0.50
$0.81
52 Week High
$3.90
$4.07

Technical Indicators

Market Signals
Indicator
UPLD
MRKR
Relative Strength Index (RSI) 36.02 65.89
Support Level $0.50 $0.86
Resistance Level $0.77 $2.29
Average True Range (ATR) 0.08 0.13
MACD 0.01 0.06
Stochastic Oscillator 17.72 85.48

Price Performance

Historical Comparison
UPLD
MRKR

About UPLD Upland Software Inc.

Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels. Geographically, the company has operations in the U.S., United Kingdom and Canada, of which United States derives maximum revenue.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

Share on Social Networks: